Sevinc Balli
Ankara, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG).
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: January 06, 2026
Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG).
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: January 06, 2026
Evolving treatment strategies for HER2-altered non-small-cell lung cancer: the rise of TKIs and ADCs.
Journal: Frontiers in oncology
Published: December 19, 2025
Clinical Course and Risk Factors Affecting Mortality in Patients with Solid Organ Malignancies and COVID-19 Infection: A Retrospective Case-Control Study.
Journal: Infectious diseases & clinical microbiology
Published: September 16, 2025
The prognostic role of the neutrophil-to-lymphocyte ratio in metastatic urothelial carcinoma.
Journal: Therapeutic advances in medical oncology
Published: April 18, 2025
Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: March 22, 2025
Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach.
Journal: Cancers
Published: November 30, 2024
Emerging Strategies in Adjuvant Immunotherapy: A Comparative Review of Bladder Cancer and Renal Cell Carcinoma Treatments.
Journal: Clinical Medicine Insights. Oncology
Published: December 11, 2023
Major and minor salivary gland cancers: A multicenter retrospective study.
Journal: Head & neck
Published: November 24, 2022
Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group.
Journal: Journal of cancer research and clinical oncology
Published: March 11, 2022
Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study.
Journal: Journal of cancer research and clinical oncology
Published: November 30, 2021
Drug Targeting of Genomic Instability in Multiple Myeloma.
Journal: Frontiers in genetics
Published: November 22, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026